Hepatocellular Carcinoma: Current Management and Future Development—Improved Outcomes with Surgical Resection
暂无分享,去创建一个
Yasuhiko Sugawara | K. Hasegawa | Y. Sugawara | N. Kokudo | Y. Kishi | Kiyoshi Hasegawa | Norihiro Kokudo | Yoji Kishi
[1] A. Luciani,et al. Liver Resection for Transplantable Hepatocellular Carcinoma: Long-Term Survival and Role of Secondary Liver Transplantation , 2009, Annals of surgery.
[2] G. Gerunda,et al. Role of transarterial chemoembolization before liver resection for hepatocarcinoma , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[3] D. Geller,et al. World Review of Laparoscopic Liver Resection—2,804 Patients , 2009, Annals of surgery.
[4] M. Makuuchi,et al. Ultrasonically guided subsegmentectomy. , 1985, Surgery, gynecology & obstetrics.
[5] K. Sugimachi,et al. Repeat hepatectomy is the most useful treatment for recurrent hepatocellular carcinoma. , 2001, Journal of hepato-biliary-pancreatic surgery.
[6] ndrea,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[7] E. Abdalla,et al. Resection Prior to Liver Transplantation for Hepatocellular Carcinoma , 2003, Annals of surgery.
[8] Bixiang Zhang,et al. Role of Mesohepatectomy with or without Transcatheter Arterial Chemoembolization for Large Centrally Located Hepatocellular Carcinoma , 2007, Digestive Surgery.
[9] M. Makuuchi,et al. One thousand fifty-six hepatectomies without mortality in 8 years. , 2003, Archives of surgery.
[10] K. Tanikawa,et al. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The liver cancer study group of japan , 1994, Cancer.
[11] S. Arii,et al. Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. , 2001, Journal of hepato-biliary-pancreatic surgery.
[12] Brice Gayet,et al. The International Position on Laparoscopic Liver Surgery: The Louisville Statement, 2008 , 2009, Annals of surgery.
[13] T. Mala,et al. Laparoscopic liver resection for malignant and benign lesions: ten-year Norwegian single-center experience. , 2010, Archives of surgery.
[14] Y. Sakamoto,et al. Efficacy of a Hepatectomy and a Tumor Thrombectomy for Hepatocellular Carcinoma with Tumor Thrombus Extending to the Main Portal Vein , 2009, Journal of Gastrointestinal Surgery.
[15] Yong Zeng,et al. A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria , 2010, Annals of surgery.
[16] R. Parks,et al. Perioperative chemotherapy with FOLFOX 4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer ( EORTC Intergroup trial 40983 ) : a randomised controlled trial , 2008 .
[17] Y. Takeda,et al. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. , 2007, Surgery.
[18] Fan Zhou,et al. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus. , 2009, American journal of surgery.
[19] W. Lau,et al. Surgical Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus , 2010, Annals of Surgical Oncology.
[20] K. Shirabe,et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. , 1996, Gastroenterology.
[21] Jung‐Ta Chen,et al. An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation. , 2000, Archives of surgery.
[22] M. Nagao,et al. Repeat liver resection for hepatocellular carcinoma. , 2001, Journal of the American College of Surgeons.
[23] K. Sung,et al. Sequential Preoperative Ipsilateral Hepatic Vein Embolization After Portal Vein Embolization to Induce Further Liver Regeneration in Patients With Hepatobiliary Malignancy , 2009, Annals of surgery.
[24] Xuan Li,et al. An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus , 2010, Journal of Cancer Research and Clinical Oncology.
[25] J. Bruix,et al. Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification , 1999, Seminars in liver disease.
[26] Zeng-chen Ma,et al. Improved Survival with Resectionafter Transcatheter ArterialChemoembolization (TACE) for Unresectable Hepatocellular Carcinoma , 1998, Digestive Surgery.
[27] Y. Maetani,et al. Living donor liver transplantation as a second‐line therapeutic strategy for patients with hepatocellular carcinoma , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[28] R. Poon,et al. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. , 1999, Annals of surgery.
[29] W. Lau,et al. Salvage Surgery Following Downstaging of Unresectable Hepatocellular Carcinoma , 2004, Annals of surgery.
[30] S. Fan,et al. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. , 2002, Journal of the American College of Surgeons.
[31] J. Vauthey,et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. , 1995, American journal of surgery.
[32] G. Dusheiko,et al. Management of hepatocellular carcinoma. , 1992, Journal of hepatology.
[33] D. Lu,et al. Liver Transplantation Criteria For Hepatocellular Carcinoma Should Be Expanded: A 22-Year Experience With 467 Patients at UCLA , 2007, Annals of surgery.
[34] R. Stephenson. A and V , 1962, The British journal of ophthalmology.
[35] Ding‐Shinn Chen,et al. Percutaneous Ethanol Injection Versus Surgical Resection for the Treatment of Small Hepatocellular Carcinoma: A Prospective Study , 2005, Annals of surgery.
[36] M. Makuuchi,et al. Surgical management for adrenal gland metastasis of hepatocellular carcinoma. , 1999, Hepato-gastroenterology.
[37] Ho‐Seong Han,et al. Feasibility of laparoscopic liver resection for tumors located in the posterosuperior segments of the liver, with a special reference to overcoming current limitations on tumor location. , 2008, Surgery.
[38] S. Fan,et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. , 1999, Annals of surgery.
[39] W. Lau,et al. A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma , 2009, Annals of surgery.
[40] Surgery or ablation for hepatocellular carcinoma. , 2009, Annals of surgery.
[41] Thomas Gruenberger,et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial , 2008, The Lancet.
[42] S. Fan,et al. Aggressive management of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locoregional therapy. , 2002, Journal of the American College of Surgeons.
[43] V. Mazzaferro,et al. Resection, transplantation, either, or both? Other pieces of the puzzle , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[44] V. Vilgrain,et al. Sequential arterial and portal vein embolizations before right hepatectomy in patients with cirrhosis and hepatocellular carcinoma , 2006, The British journal of surgery.
[45] Z. Tang,et al. Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma. , 1998, Digestive surgery.
[46] T. Pawlik,et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. , 2005, Surgery.
[47] H. Hasegawa,et al. A Prospective Randomized Trial of the Preventive Effect of Pre‐operative Transcatheter Arterial Embolization against Recurrence of Hepatocellular Carcinoma , 1996, Japanese journal of cancer research : Gann.
[48] J. Joh,et al. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: Comparison between cadaveric donor and living donor liver transplantations , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[49] Tse-Ching Chen,et al. Efficacy of surgical resection in management of isolated extrahepatic metastases of hepatocellular carcinoma. , 2009, World journal of gastroenterology.
[50] H. Eguchi,et al. The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. , 2006, American journal of surgery.
[51] Y. Takeda,et al. Interferon‐α and 5‐fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules , 2007, Cancer.
[52] C. Ker,et al. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes , 2009, Journal of surgical oncology.
[53] Alan J. Koffron,et al. Evaluation of 300 Minimally Invasive Liver Resections at a Single Institution: Less Is More , 2007, Annals of surgery.
[54] Cheng‐Chung Wu,et al. Second and third hepatectomies for recurrent hepatocellular carcinoma are justified , 2009, The British journal of surgery.
[55] Dieter Häussinger,et al. Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.
[56] E. Gregoire,et al. Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature. A European case-control series , 2006, Journal of Gastrointestinal Surgery.
[57] M. Makuuchi,et al. Living Donor Liver Transplantation for Hepatocellular Carcinoma: Tokyo University Series , 2007, Digestive Diseases.
[58] Yih-Leong Chang,et al. Prognostic Factors for Pulmonary Metastasectomy in Hepatocellular Carcinoma , 2006, Annals of Surgical Oncology.
[59] Y. Maehara,et al. Extended Indication for Living Donor Liver Transplantation in Patients With Hepatocellular Carcinoma , 2007, Transplantation.
[60] S. Paggi,et al. Sorafenib in Advanced Hepatocellular Carcinoma , 2008 .
[61] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[62] Y. Takeda,et al. Prognosis of hepatocellular carcinoma with biliary tumor thrombi after liver surgery. , 2011, Surgery.
[63] M. Makuuchi,et al. Preemptive Therapy for Hepatitis C Virus after Living-Donor Liver Transplantation , 2004, Transplantation.
[64] J. Bruix,et al. Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.
[65] R. Baron,et al. Extrahepatic metastases of hepatocellular carcinoma. , 2000, Radiology.
[66] F. P'eng,et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: A reappraisal , 1995, The British journal of surgery.
[67] V. Paradis,et al. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis , 2009, Hepatology.
[68] W. Lau,et al. A Prospective Randomized Trial Comparing Percutaneous Local Ablative Therapy and Partial Hepatectomy for Small Hepatocellular Carcinoma , 2006, Annals of surgery.
[69] 日本肝癌研究会. General rules for the clinical and pathological study of primary liver cancer , 2010 .
[70] B. Xing,et al. Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy: therapeutic efficacy on early- and late-phase recurrence. , 2006, AJR. American journal of roentgenology.
[71] S. Curley,et al. Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival. , 2009, Surgery.
[72] M. Tsuneyoshi,et al. Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis , 1993, Cancer.
[73] M. Makuuchi,et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. , 2004, Archives of surgery.
[74] S. Kawasaki,et al. Prognostic significance of anatomical resection and des‐γ‐carboxy prothrombin in patients with hepatocellular carcinoma , 1999, The British journal of surgery.
[75] A. Benson,et al. Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis , 2007, Hepatology.
[76] J. Figueras,et al. Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: Results of a prospective randomized study , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[77] Ho‐Seong Han,et al. Total laparoscopic liver resection for hepatocellular carcinoma located in all segments of the liver , 2010, Surgical Endoscopy.
[78] S. Giulini,et al. Sequential multidisciplinary treatment of hepatocellular carcinoma: The role of surgery as rescue therapy for failure of percutaneous ablation therapies , 2009, Journal of surgical oncology.
[79] N. Nagasue,et al. Role of Preoperative Transcatheter Arterial Oily Chemoembolization for Resectable Hepatocellular Carcinoma , 1996, World Journal of Surgery.
[80] M. Gonen,et al. Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma , 2005, Cancer.
[81] A. Ponti,et al. The Learning Curve in Laparoscopic Liver Resection: Improved Feasibility and Reproducibility , 2009, Annals of surgery.
[82] D. Suh,et al. Pre‐operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post‐operative patient outcome , 2007, Alimentary pharmacology & therapeutics.
[83] M. Abecassis,et al. Yttrium‐90 microspheres (TheraSphere®) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation , 2006, Journal of surgical oncology.
[84] L Pagliaro,et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. , 2001, Journal of hepatology.
[85] E. Hatano,et al. Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. , 2006, Journal of the American College of Surgeons.
[86] L. Capussotti,et al. Liver resection for HCC with cirrhosis: surgical perspectives out of EASL/AASLD guidelines. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[87] M. Makuuchi,et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. , 1990, Surgery.
[88] Bernard Paule,et al. Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.
[89] S. Yajima,et al. Laparoscopic hepatectomy for hepatocellular carcinoma in cirrhotic patients. , 2009, Journal of hepato-biliary-pancreatic surgery.
[90] M. Makuuchi,et al. Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? , 2009, Surgery.
[91] S. Katagiri,et al. Effectiveness of systematized hepatectomy with Glisson's pedicle transection at the hepatic hilus for small nodular hepatocellular carcinoma: retrospective analysis. , 2001, Surgery.
[92] Yutaka Matsuyama,et al. Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.
[93] S. Fan,et al. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence , 2000, Journal of surgical oncology.
[94] I. Bilbao,et al. Resection for hepatocellular carcinoma is a good option in Child‐Turcotte‐Pugh class A patients with cirrhosis who are eligible for liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[95] A. Venook,et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.
[96] T. Asahara,et al. Repeat hepatectomy for recurrent hepatocellular carcinoma. , 2007, Surgery.
[97] N. Nagasue,et al. Repeat hepatectomy for recurrent hepatocellular carcinoma , 1996, The British journal of surgery.
[98] S. Todo,et al. The impact of anatomical resection for hepatocellular carcinoma that meets the milan criteria , 2010, Journal of surgical oncology.
[99] W. Marsden. I and J , 2012 .
[100] Guy Brock,et al. Experience With More Than 500 Minimally Invasive Hepatic Procedures , 2008, Annals of surgery.
[101] S. Futagawa,et al. Role of Preoperative Transcatheter Arterial Chemoembolization for Resectable Hepatocellular Carcinoma: Relation between Postoperative Course and the Pattern of Tumor Recurrence , 2003, World Journal of Surgery.
[102] A. Zhu,et al. Liver transplantation outcomes for early‐stage hepatocellular carcinoma: Results of a multicenter study , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[103] H. Yoshida,et al. Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors , 2008, Liver international : official journal of the International Association for the Study of the Liver.
[104] M. Makuuchi,et al. Selection Criteria for Repeat Hepatectomy in Patients With Recurrent Hepatocellular Carcinoma , 2003, Annals of surgery.
[105] S. Uemoto,et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[106] C. Wai,et al. Long Term Outcome and Prognostic Factors for Large Hepatocellular Carcinoma (10 cm or more) after Surgical Resection , 2007, Annals of Surgical Oncology.
[107] Byung Chul Yoo,et al. Percutaneous Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma After Hepatectomy: Long-term Results and Prognostic Factors , 2007, Annals of Surgical Oncology.
[108] K. Saigenji,et al. Repeat Radiofrequency Ablation Provides Survival Benefit in Patients With Intrahepatic Distant Recurrence of Hepatocellular Carcinoma , 2009, The American Journal of Gastroenterology.
[109] J. Choi,et al. Is Preoperative Transarterial Chemoembolization Needed for a Resectable Hepatocellular Carcinoma? , 2007, World Journal of Surgery.
[110] G. Honda,et al. Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi. , 2000, Surgery.
[111] M. Makuuchi,et al. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. , 2008, Surgery.
[112] G. Otto,et al. Early Steroid-Free Immunosuppression With FK506 After Liver Transplantation: Long-Term Results of a Prospectively Randomized Double-Blinded Trial , 2010, Transplantation.
[113] O. Matsui,et al. Postoperative adjuvant hepatic arterial infusion of lipiodol containing anticancer drugs in patients with hepatocellular carcinoma , 1994, Hepatology.
[114] N. O'Rourke,et al. Laparoscopic right hepatectomy: Surgical technique , 2004, Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract.
[115] J. Bruix,et al. Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials , 1999, Hepatology.
[116] M. Omata,et al. Combination therapy of intraarterial 5‐fluorouracil and systemic interferon‐alpha for advanced hepatocellular carcinoma with portal venous invasion , 2006, Cancer.
[117] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[118] M. Makuuchi,et al. Selection Criteria for Hepatectomy in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus , 2001, Annals of surgery.
[119] M. Makuuchi,et al. Cyclosporin a for treatment of hepatitis C virus after liver transplantation. , 2006, Transplantation.
[120] Y. Karino,et al. Clinical features of hepatocellular carcinoma with extrahepatic metastases , 2005, Journal of gastroenterology and hepatology.
[121] Alexis Laurent,et al. Laparoscopic liver resection for subcapsular hepatocellular carcinoma complicating chronic liver disease. , 2003, Archives of surgery.
[122] M. Makuuchi,et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. , 2008, Gastroenterology.
[123] L. Ellis,et al. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[124] Y. Iwashita,et al. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[125] Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction. , 2006, Anticancer research.
[126] T. Inoue,et al. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? , 1996, Annals of surgery.
[127] F. Lévi,et al. Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[128] E. Hatano,et al. Implication of Frequent Local Ablation Therapy for Intrahepatic Recurrence in Prolonged Survival of Patients With Hepatocellular Carcinoma Undergoing Hepatic Resection: An Analysis of 610 Patients Over 16 Years Old , 2006, Annals of surgery.
[129] S. Todo,et al. Living Donor Liver Transplantation for Adult Patients With Hepatocellular Carcinoma: Experience in Japan , 2004, Annals of surgery.
[130] K. Sugimachi,et al. Impact of Des-Gamma-Carboxy Prothrombin and Tumor Size on the Recurrence of Hepatocellular Carcinoma After Living Donor Liver Transplantation , 2009, Transplantation.
[131] K. Chijiiwa,et al. Clinicopathologic Characteristics of Hepatocellular Carcinoma with Bile Duct Invasion , 2009, Journal of Gastrointestinal Surgery.
[132] W. Lau,et al. Preoperative Systemic Chemoimmunotherapy and Sequential Resection for Unresectable Hepatocellular Carcinoma , 2001, Annals of surgery.
[133] P. Lainas,et al. Laparoscopic hepatectomy for hepatocellular carcinoma: a European experience. , 2010, Journal of the American College of Surgeons.
[134] G. Chau,et al. Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter , 1998, The British journal of surgery.
[135] Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer , 2006, The Japanese journal of surgery.
[136] M. Makuuchi,et al. Pre‐emptive antiviral therapy in living donor liver transplantation for hepatitis C: observation based on a single‐center experience , 2009, Transplant international : official journal of the European Society for Organ Transplantation.
[137] M. Makuuchi,et al. Prognostic Impact of Anatomic Resection for Hepatocellular Carcinoma , 2005, Annals of surgery.
[138] G. Belli,et al. Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short- and middle-term results , 2007, Surgical Endoscopy.
[139] K Arai,et al. Small hepatocellular carcinoma: treatment with subsegmental transcatheter arterial embolization. , 1993, Radiology.
[140] L. Ferrell,et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. , 2000, Journal of hepatology.